If you and your doctor agree that Sprycel is working well for you, the drug is typically a long-term treatment. As with other drugs, Sprycel can cause side effects. Read on to learn about potential ...
Sprycel (dasatinib) is a prescription drug used to treat certain types of leukemia. Sprycel’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you ...
Sprycel (dasatinib) is a prescription drug that’s used to treat certain types of leukemia. The drug comes as an oral tablet that you usually take once per day. * The Philadelphia chromosome is an ...
Sprycel (dasatinib) is a brand-name oral tablet. It’s prescribed for specific types of leukemia in certain adults and children. Sprycel has interactions with other drugs and certain supplements.
PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SPRYCEL ® (dasatinib) Support, a useful ...
SPRYCEL® (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec®* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved new labeling for SPRYCEL to include a lower ...
Oncologists have begun trading in what had become a miracle pill for patients with chronic myeloid leukemia for more potent, newer-generation drugs that appear to work even better as first-line ...
SPRYCEL, an oral BCR-ABL inhibitor, is currently approved by the FDA for the treatment of adults for all phases of CML (chronic, accelerated, or myeloid or lymphoid blast phase) with resistance or ...
Sprycel (dasatinib) was granted a supplemental new drug application (sNDA) by the Food and Drug Administration (FDA) to treat children with Philadelphia chromosome-positive chronic phase chronic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Bristol-Myers Squibb Company BMY announced that the European Commission (EC) has approved its oncology drug Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results